Brief: Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
24/06/2025 14:07
June 24 (Reuters) - Candel Therapeutics Inc CADL.O: CANDEL THERAPEUTICS ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING OF COMMON STOCK CANDEL THERAPEUTICS INC - TO SELL 3.2 MILLION SHARES AT $4.67 EACH CANDEL THERAPEUTICS INC - PROCEEDS TO SUPPORT LAUNCH READINESS AND BLA SUBMISSION FOR CAN-2409 Source text: ID:nGNXbZsCg8 Further company coverage: CADL.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Candel Therapeutics
See all newsBrief: Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints In Patients From Phase 3 Trial Of Aglatimagene Besadenovec (Can-2409)
Candel Therapeutics reports Q1 loss
Brief: Candel Therapeutics Q1 Net Income USD -8.861 Million
Brief: Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Candel Therapeutics Inc Extended Survival Tail Observed In Trial Of Aglatimagene Besadenovec